- PROFESSOR | Pediatrics, Newborn Medicine
- PROFESSOR | Obstetrics, Gynecology and Reproductive Science
- Pediatrics Neonatal-Perinatal Medicine
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Klingenstein Pavilion 212-241-6186212-241-6186
He presently serves as the Vice Chair for Hospital Operations and Faculty Affairs in the Jack and Lucy Clark Department of Pediatrics. Among other responsibilities, Dr. Holzman is the President of the Independent Physicians Organization, the Chair of the Ethics Committee and the In-Patient Operations Committee, and a member of the Board of Governors of the Faculty Practice Association. He also serves on the Hospital Professionalism Committee, the Credentials Committee, the Appointments and Promotions Committee, the Emergency Management Committee and various Quality Assurance Committees. Dr. Holzman also serves as the Director of Newborn Services for the Mount Sinai Health System.
Neonatal & Perinatal Medicine
American Board of Pediatrics
- Anoxic Brain Damage
- Intubation And Mechanical Ventilation
- Necrotizing Enterocolitis
- Neonatal Sepsis
- Patent Ductus Arteriosus
- Persistent Pulmonary Hypertension
- Premature Birth
- Respiratory Distress Syndrome
- Small Bowel Obstruction
MD, University of Pittsburgh
Children's Hospital of Pittsburgh
Children's Hospital of Pittsburgh
Fellowship, Perinatal Medicine
University of Colorado
New York Magazine
Dr. Holzman’s research interests include understanding the etiology of necrotizing enterocolitis, examining treatment strategies for breathing problems in newborns and nutritional practices in the neonatal intensive care unit. He also works in the area of bioethics with a special interest in problems related to newborns and in surrogate decision-making.
Rhodes R, Holzman IR. Is The Best Interest Standard Good for Pediatrics?. Pediatrics 2014; 134: S121-S129.
Holzman IR. Clincal Ethics in Pediatrics: A Case-Based Textbook 2011. Cambridge University Press;.
Schulman J, Stricoff R, Stevens T, Horgan M, Gase K, Holzman IR. Statewide decline in NICU central line associated bloodstream infection rates after implementing bundles and checklists. Pediatrics 2010; 127: 436-444.
Howell EA, Holzman IR. Surfactant use for premature infants with respiratory distress syndrome in three New York City hospitals: discordance of practice from a community consensus standard. Journal of Perinatology 2010; 30: 590-595.
Gibbs KA, Kleinman LC, Jenkins SG, Herold BC, Holzman IR. The vulnerable very low birth weight infant: Late onset bloodstream infections. Journal of Neonatal-Perinatal Medicine 2010; 3: 117-125.
Holzman IR. Commentary: calibrating the moral compass. Cambridge Quarterly of Healthcare Ethics 2010; 19: 411-413.
Hyman SJ, Novoa Y, Holzman IR. Perinatal endocrinology: Common endocrine disorders in the sick and premature infant. Endocrinology and Metabolism Clinics of North America 2009; 38: 509-524.
Holzman IR. Committee on Bioethics, Policy Statement. Contributing author. Physician refusal to provide information or treatment on the basis of claims of conscience. Pediatrics 2009; 124: 1689-1693.
Holzman IR. Policy statement (American Academy of Pediatrics):Pediatrician-family-patient relationships: Managing the boundaries. Pediatrics 2009; 124: 1685-1688.
Schulman J, Stricof RI, Stevens TP, Holzman IR. Development of a statewide collaborative to decrease NICU central line associated bloodstream infections. Journal of Perinatology 2009; 29: 591-599.
Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intensital barrier by facilitating tight junction assembly via activation of AMP activated protein kinase in Cao-2 cell monolayers. Journal of Nutrition 2009; 139: 1619-25.
Hempel B, Holzman IR. End of life decision making regarding infants of artificial reproductive techniques and spontaneous conception. Journal of Neonatal-Perinatal Medicine 2008; 1: 31-35.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Holzman did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.